• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Model Number VXAK0003
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 04/24/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.We are unable to provide the complete unique identifier (udi) at the time of the submission of this report, as it was not yet available.If additional details become available, a supplemental report will be submitted.
 
Event or Problem Description
A thrombosis has occurred.The procedure was cancelled.It was reported that during a watchman left atrial appendage closure (laac) procedure, a versacross connect laac kit was selected for use.During the procedure a transeptal puncture was performed with a versacross connect and trusteer sheath.When the versacross rf wire was removed, a mobile object was noted on the tip of the coumadin ridge.It was not possible to determine whether it was a tissue fragment or a thrombus.The physician decided to keep the patient on oral anticoagulation (oac) and reschedule the procedure on a later date.There were no patient complications, and the patient was discharged the same day.The device is not expected to be returned for analysis (disposed).Half dose of heparin was given before transseptal and half was given after.Act was measured as 307 seconds.The patient was sent home same day.The physicians want to keep the patient on oac and re-image.
 
Additional Manufacturer Narrative
The device did not return for analysis.However, the reported allegation of thrombosis was confirmed based on the media provided.We are unable to provide the complete unique identifier (udi) at the time of the submission of this report, as it was not yet available.If additional details become available, a supplemental report will be submitted.
 
Event or Problem Description
A thrombosis has occurred.The procedure was cancelled.It was reported that during a watchman left atrial appendage closure (laac) procedure, a versacross connect laac kit was selected for use.During the procedure a transeptal puncture was performed with a versacross connect and trusteer sheath.When the versacross rf wire was removed, a mobile object was noted on the tip of the coumadin ridge.It was not possible to determine whether it was a tissue fragment or a thrombus.The physician decided to keep the patient on oral anticoagulation (oac) and reschedule the procedure on a later date.There were no patient complications, and the patient was discharged the same day.The device is not expected to be returned for analysis (disposed).Half dose of heparin was given before transseptal and half was given after.Act was measured as 307 seconds.The patient was sent home same day.The physicians want to keep the patient on oac and re-image.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICALE CIE INC
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
zona franca la lima
cartgo, 03 30106
CS   30106
Manufacturer Contact
mary crawford
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key22019067
Report Number2124215-2025-30969
Device Sequence Number13132471
Product Code DXF
UDI-Device Identifier00685447018346
UDI-Public(01)00685447018346
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K150709
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberVXAK0003
Device Catalogue NumberVXAK0003
Device Lot Number0035565933
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/24/2025
Supplement Date Received by Manufacturer05/30/2025
Initial Report FDA Received Date05/14/2025
Supplement Report FDA Received Date06/19/2025
Date Device Manufactured10/15/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age81 YR
Patient SexFemale
Patient RaceWhite
-
-